LivaNova News - LIVN

Company Name	Stock Ticker Symbol	Market	Type
LivaNova PLC	LIVN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	5.99	11.09%	60.00	19:27:23

Open Price	Low Price	High Price	Close Price	Prev Close
53.80	53.39	55.39	55.02	54.01

more quote information »

Recent News

Date	Time	Source	Heading
3/21/2024	09:00	BW	LivaNova to Announce First-Quarter 2024 Results
3/20/2024	09:00	BW	LivaNova Announces a Positive Predictive Outcome of Trial..
3/11/2024	16:47	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
3/05/2024	21:55	EDGAR2	Form 8-K - Current report
3/05/2024	21:55	BW	LivaNova Announces Pricing of Private Offering of $300..
3/04/2024	17:24	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
3/04/2024	17:22	EDGAR2	Form 8-K - Current report
3/04/2024	16:44	BW	LivaNova Announces Proposed Private Offering of $300 Million..
3/04/2024	09:00	BW	LivaNova to Present at the Barclays Global Healthcare..
2/29/2024	13:26	EDGAR2	Form IRANNOTICE - Notice of disclosure filed pursuant to..
2/29/2024	13:24	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/21/2024	06:03	EDGAR2	Form 8-K - Current report
2/21/2024	06:00	BW	LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
2/05/2024	08:11	EDGAR2	Form 8-K - Current report
2/05/2024	08:00	BW	LivaNova Announces Vladimir A. Makatsaria as CEO and Board..
1/08/2024	08:32	EDGAR2	Form 8-K - Current report
1/08/2024	08:30	BW	LivaNova to Wind Down Advanced Circulatory Support Business..
1/04/2024	09:00	BW	LivaNova to Announce Fourth-Quarter and Full-Year 2023..
12/19/2023	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/13/2023	08:30	EDGAR2	Form 8-K - Current report
12/06/2023	07:00	EDGAR2	Form 8-K - Current report
11/20/2023	17:15	EDGAR2	Form 8-K - Current report
11/09/2023	09:00	BW	LivaNova to Present at the Piper Sandler Healthcare..
11/01/2023	15:03	EDGAR2	Form IRANNOTICE - Notice of disclosure filed pursuant to..
11/01/2023	15:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	06:05	EDGAR2	Form 8-K - Current report
11/01/2023	06:00	BW	LivaNova Reports Third-Quarter 2023 Results
10/25/2023	09:00	BW	LivaNova to Present at the Stifel and Wolfe Healthcare..
10/19/2023	16:09	EDGAR2	Form 8-K - Current report
10/13/2023	16:46	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/06/2023	08:41	EDGAR2	Form 8-K - Current report
10/06/2023	08:30	BW	LivaNova Board Appoints J. Christopher Barry as New Director
9/21/2023	16:20	EDGAR2	Form 8-K/A - Current report: [Amend]
9/21/2023	07:09	EDGAR2	Form 8-K - Current report
9/21/2023	07:00	BW	LivaNova Announces Marco Dolci, President of..
9/20/2023	09:00	BW	LivaNova to Announce Third-Quarter 2023 Results
9/19/2023	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	18:57	BW	LivaNova präsentiert Essenz In-Line Blood Monitor mit U.S...
8/30/2023	18:39	BW	LivaNova dévoile son moniteur de sang en ligne Essenz, qui..
8/30/2023	16:05	BW	LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA..
8/24/2023	09:00	BW	LivaNova to Present at the Baird Global Healthcare..
7/26/2023	15:33	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
7/26/2023	15:24	EDGAR2	Form IRANNOTICE - Notice of disclosure filed pursuant to..
7/26/2023	15:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/26/2023	06:05	EDGAR2	Form 8-K - Current report
7/26/2023	06:00	BW	LivaNova Reports Second-Quarter 2023 Results
6/14/2023	09:00	BW	LivaNova to Announce Second-Quarter 2023 Results
6/13/2023	09:00	BW	LivaNova Announces 150th Bipolar Depression Patient..